Commercial Tanning Bed Treatment is an Effective Psoriasis Treatment: Results from an Uncontrolled Trial

  • Alan B. FleischerJr.


Phototherapy with artificial light sources represents one of the most important therapeutic advances in psoriasis treatment in the twentieth century (Weinstein and Gottleib, 1993) (Farber, 1995) (Greaves and Weinstein, 1995). Unfortunately, phototherapy is often unavailable in rural areas, and expense precludes some patients from visiting these facilities. By contrast, commercial tanning facilities are universal. Although there are only approximately 7,000 practicing dermatologists with likely less than 1,000 ultraviolet treatment facilities, there are over 27,000 tanning salons in the United Sates.


Psoriasis Patient Brief Symptom Inventory Indoor Tanning Localize Scleroderma Psoriasis Area Severity Index 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berth-Jones J, Chu AC, Dodd WA, et al: A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. BrJDermatol 127(3):266–71, 1992.PubMedCrossRefGoogle Scholar
  2. Boer J, Schothorst AA, Suurmond D: Influence of UVA on the erythematogenic and therapeutic effects of UVB irradiation in psoriasis; photoaugmentation effects. J Invest Dermatol 76(1):56–8, 1981.PubMedCrossRefGoogle Scholar
  3. Clark AR, Feldman SR, Fleischer AB Jr: The elderly patient tolerates phototherapy as well as the younger patient. J Ger Dermatol 4:1–6, 1996.Google Scholar
  4. Cohen S, Kamarek T, Mermelstein R: A global measure of perceived stress. J Health Soc Beh 24:385–396, 1983.CrossRefGoogle Scholar
  5. Cunliffe WJ, Berth-Jones J, Claudy A, et al.: Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. JAm Acad Dermatol 26(5 Pt 1):736–43, 1992.CrossRefGoogle Scholar
  6. Derogatis LR, Spencer PM: The Brief Symptom Inventory (BSI): Administration, scoring and procedures manual Baltimore, MD, Johns Hopkins Press, 1982.Google Scholar
  7. Diette KM, Momtaz K, Stem RS, Arndt KA, Parrish JA: Role of ultraviolet A in phototherapy for psoriasis. JAm Acad Dermatol 11:441–7, 1984.CrossRefGoogle Scholar
  8. Diffey BL: Use of UV-A sunbeds for cosmetic tanning Br J Dermatol 115:67–76, 1986.PubMedCrossRefGoogle Scholar
  9. Farber EM: Therapeutic perspectives in psoriasis. Int J Dermatol 34:456–60, 1995.PubMedCrossRefGoogle Scholar
  10. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L: The self-administered psoriasis area severity index is a valid and reliable instrument. J Invest Dermatol 106:183–6, 1996.PubMedCrossRefGoogle Scholar
  11. Fleischer AB Jr, Feldman SR, Rapp SR, Reboussin DR, Exum ML, Clark AR, Rajashekhar V: Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with the self-administered psoriasis area severity index scores. Jlnvest Dermatol 107:26–29, 1996.CrossRefGoogle Scholar
  12. Fleischer AB Jr, Feldman SR, Rapp SR, Reboussin DR, Exum ML, Clark AR: Alternative therapies are commonly used within a population of psoriasis patients. Cutis 58:216–220, 1996.PubMedGoogle Scholar
  13. Fleischer AB Jr, Lee WJ, Adams DP, Zanolli MD: Tanning facility compliance with State and Federal regulations in North Carolina: a poor performance. JAm Acad Dermatol 28:212–217, 1993.CrossRefGoogle Scholar
  14. Fleischer AB Jr, Rapp SR, Reboussin DM, Vanarthos JC, Feldman SR: Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol 102:967–969, 1994.PubMedCrossRefGoogle Scholar
  15. Fredriksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238–244, 1978.PubMedCrossRefGoogle Scholar
  16. Greaves MW, Weinstein GD: Treatment of psoriasis. NEngl JMed 332;:581–8, 1995.CrossRefGoogle Scholar
  17. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M, et al: Low-dose UVA phototherapy for treatment of localized scleroderma. JAm Acad Dermatol 1998;38:21–6.CrossRefGoogle Scholar
  18. Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Sonnichsen N, et al: High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. JAm Acad Dermatol 1998;38:589–93.CrossRefGoogle Scholar
  19. Parrish JA: Treatment of psoriasis with long-wave ultraviolet light. Arch Dermatol 113(11):1525–8, 1977.PubMedCrossRefGoogle Scholar
  20. Schopf RE, Hocher J, Rehder M, Farber L, Morsches B: Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis. Arch Dermatol Res 284(4):227–31, 1992.PubMedCrossRefGoogle Scholar
  21. Weinstein GD, Gottleib AB: Therapy of Moderate-to-Severe Psoriasis National Psoriasis Foundation, Portland, 1993Google Scholar
  22. Weinstock MA: Assessment of sun sensitivity by questionnaire: validity of items and formulation of a predictive rule. J Clin Epidemiol 45:547–552, 1992.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Alan B. FleischerJr.

There are no affiliations available

Personalised recommendations